Ageing and infection

Lancet Infectious Diseases

Volumn 2, Issue 11, 2002, Pages 659-666

  Gavazzi, Gaëtan ^a   Krause, Karl Heinz ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Biology of Ageing Laboratory   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BETA LACTAM ANTIBIOTIC; C REACTIVE PROTEIN; CEFEPIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM; INFLUENZA VACCINE; ISONIAZID; MACROLIDE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; PROCALCITONIN; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN; WARFARIN;

AGED; AGING; ANAPHYLAXIS; ANTIBIOTIC THERAPY; ATHEROSCLEROSIS; ATROPHIC GASTRITIS; BACTERIAL INFECTION; BLOOD DYSCRASIA; BONE MARROW SUPPRESSION; BRAIN DISEASE; CHLAMYDOPHILA PNEUMONIAE; COLITIS; COMORBIDITY; CYTOMEGALOVIRUS; DELIRIUM; DEMENTIA; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE PREDISPOSITION; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; GASTROENTERITIS; GASTROINTESTINAL DISEASE; GERIATRIC CARE; GERIATRIC PATIENT; HEART FAILURE; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; INFECTION; INFECTION CONTROL; INFLAMMATION; INFLUENZA; KIDNEY FAILURE; MALNUTRITION; MEDICAL DECISION MAKING; MEDICAL ETHICS; NAUSEA; NEPHROTOXICITY; NURSING HOME; OTOTOXICITY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SEIZURE; SLEEP DISORDER; TENDINITIS; THORAX RADIOGRAPHY; TOXIC HEPATITIS; TREATMENT INDICATION; URINARY TRACT INFECTION; VACCINATION; VIRUS INFECTION;

EID: 0036840992     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(02)00437-1     Document Type: Review

References (120)

1. Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 2000; 30: 931-33.
2. Yoshikawa TT. Perspective: Aging and infectious diseases: Past, present, and future. J Infect Dis 1997; 176: 1053-57.
3. Krause KH. Geriatric infectious diseases program. In: Michel JP and Hof PR, eds. Management of Ageing. Basel: Karger, 1999: pp77-80.
4. Osler W. The Principles and Practice of Medicine. 3rd Edn. New York: D Appelton and Co, 1899.
5. Choi C. Bacterial meningitis in aging adults. Clin Infect Dis 2001; 33: 1380-85.
6. Dhawan VK. Infective endocarditis in elderly patients. Clin Infect Dis 2002; 34: 806-12.
7. Fein AM. Pneumonia in the elderly: Overview of diagnostic and therapeutic approaches. Clin Infect Dis 1999; 28: 726-29.
8. Marrie TJ. Community-acquired pneumonia in the elderly. Clin Infect Dis 2000; 31: 1066-78.
9. Nicolle LE. Urinary tract infection in geriatric and institutionalized patients. Curr Opin Urol 2002; 12: 51-55.
10. Reacher MH, Shah A, Livermore DM, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: Trend analysis. BMJ 2000; 320: 213-16.
11. Leibovici L. Bacteraemia in the very old. Features and treatment. Drugs Aging 1995; 6: 456-64.
12. Emori TG, Banerjee SN, Culver DH, et al. Nosocomial infections in elderly patients in the United States, 1986-1990, National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 289S-93S.
13. Garibaldi RA. Residential care and the elderly: The burden of infection. J Hosp Inject 1999; 43: S9-18.
14. Stocks G, Janssen HF. Infection in patients after implantation of an orthopedic device. ASAIO J 2000; 46: S41-46
15. Rajagopalan S. Tuberculosis and aging: A global health problem. Clin Infect Dis 2001; 33: 1034-39.
16. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: Impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160: 397-405.
17. Schmader K. Herpes zoster in the elderly: Issues related to geriatrics. Clin Infect Dis 1999; 28: 736-39.
18. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; 17: S3-10.
19. Leibovici L, Pitlik SD, Konisberger H, Drucker M. Bloodstream infections in patients older than eighty years. Age Ageing 1993; 22: 431-42.
20. Gavazzi G, Mallaret M, Couturier P, Iffenecker A, Franco A. Bloodstream infection in the elderly: Differences between young old, old and very old patients. J Am Geriatr Soc 2002 (in press).
21. Janssens JP, Gauthey L, Herrmann F, Tkatch L, Michel JP. Community-acquired pneumonia in older patients. J Am Geriatr Soc 1996; 44: 539-44.
22. Nicolle LE. Infection control in long-term care facilities. Clin Infect Dis 2000; 31: 752-56.
23. Macfarlane JT, Storr A, Wart MJ, Smith WH. Safety, usefulness and acceptability of fibreoptic bronchoscopy in the elderly. Age Ageing 1981; 10: 127-31.
24. Lombardi C, Spedini C, Lanzani G. Fiber bronchoscopy in old age. Its diagnostic importance, tolerability and safety. Recenti Prog Med 1995; 86: 17-20.
25. Chassagne P, Perol MB, Doucet J, et al. Is presentation of bacteremia in the elderly the same as in younger patients? Am J Med 1996; 100: 65-70.
26. Cooper GS, Shlaes DM, Salata RA. Intraabdominal infection: Differences in presentation and outcome between younger patients and the elderly. Clin Infect Dis 1994; 19: 146-48.
27. Jarrett PG, Rockwood K, Carver D, Stolee P, Cosway S. Illness presentation in elderly patients. Arch Intern Med 1995; 155: 1060-64.
28. Norman DC, Toledo SD. Infections in elderly persons. An altered clinical presentation. Clin Geriatr Med 1992;8:713-19.
29. Norman DC, Yoshikawa TT. Fever in the elderly. Infect Dis Clin North Am 1996; 10: 93-99.
30. Trivalle C, Doucet J, Chassagne P, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996; 44: 50-53.
31. Knockaert DC, Vanneste LJ, Bobbaers HJ. Fever of unknown origin in elderly patients. J Am Geriatr Soc 1993; 41: 1187-92.
32. Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M. Neutrophil ageing and immunesenescence. Mech Ageing Dev 2001; 122: 1521-35.
33. Pfitzenmeyer P, Decrey H, Auckenthaler R, Michel JP. Predicting bacteremia in older patients. J Am Geriatr Soc 1995; 43: 230-35.
34. Reinhart K, Karzai W, Melsner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000; 26: 1193-200.
35. Povoa P. C-reactive protein: A valuable marker of sepsis. Intensive Care Med 2002; 28: 235-43.
36. Povoa P, Almeida E, Moreira P, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998; 24: 1052-56.
37. Hogarth MB, Gallimore R, Savage P, et al. Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient. Age Ageing 1997; 26: 153-58.
38. Ross RD, Frengley JD, Mion LC, Kushner I. Elevated C-reactive protein in older people. J Am Geriatr Soc 1992; 40: 104-05.
39. Werner GS, Schulz R, Fuchs JB, et al. Infective endocarditis in the elderly in the era of transesophageal echocardiography: Clinical features and prognosis compared with younger patients. Am J Med 1996; 100: 90-79.
40. Borrego F, Gleckman R. Principles of antibiotic prescribing in the elderly. Drugs Aging 1997; 11: 7-18.
41. McCusker J, Cole M, Dendukuri N, Belzile E, Primeau F. Delirium in older medical inpatients and subsequent cognitive and functional status: A prospective study. CMAJ 2001; 165: 575-83.
42. Levkoff S, Cleary P, Liptzin B, Evans DA. Epidemiology of delirium: An overview of research issues and findings. Int Psychogeriatr 1991; 3: 149-67.
43. McCue JD. Antibiotic use in the elderly: Issues and nonissues. Clin Infect Dis 1999; 28: 750-52.
44. Claesson S, Morrison A, Wertheimer AI, Berger ML. Compliance with prescribed drugs: Challenges for the elderly population. Pharm World Sci 1999; 21: 256-59.
45. Thwaites JH. Practical aspects of drug treatment in elderly patients with mobility problems. Drugs Aging 1999; 14: 105-14.
46. Beyth RJ, Short RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging 1999; 14: 231-39.
47. Walker J, Wynne H. Review: The frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994; 23: 255-59.
48. Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87-94.
49. Veehof LJ, Stewart RE, Meyboom-de Jong B, Haaijer-Ruskamp FM. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999; 55: 533-36.
50. Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotictreated hospitalized patients: A prospective study. J Antimicrob Chemother 2001; 47: 43-50.
51. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-39.
52. Novotny J, Novotny M. Adverse drug reactions to antibiotics and major antibiotic drug interactions. Gen Physiol Biophys 1999; 18: 126-39.
53. Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults: A prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944-48.
54. Rajagopalan S, Yoshikawa TT. Antimicrobial therapy in the elderly. Med Clin North Am 2001; 85: 133-47.
55. Pestotnik SL, Classen DC, Evans RS, Stevens LE, Burke JP. Prospective surveillance of imipenem/cilastatin use and associated seizures using a hospital information system. Ann Pharmacother 1993; 27: 497-501.
56. Jallon P, Fankhauser L, Du Pasquier R, et al. Severe but reversible encephalopathy associated with cefepime. Neurophysiol Clin 2000; 30: 383-86.
57. van den Brande P, van Steenbergen W, Vervoort G, Demedts M. Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis. Am J Respir Crit Care Med 1995; 152: 1705-08.
58. Veyssier P. les antibiotiques chez le sujet âgé. In: Veyssier P, ed. Infections chez les sujets âgés. Paris: Ellipses, 1997: 21.
59. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of two management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001; 32: 419-30
60. Natsch S, Kullberg BJ, van der Meer JW, Meis JF. Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections. Eur J Clin Microbiol Infect Dis 1998; 17: 681-84.
61. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080-84.
62. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379-86.
63. Deulofeu F, Cervello B, Capell S, Marti C, Mercade V. Predictors of mortality in patients with bacteremia: The importance of functional status. J Am Geriatr Soc 1998;46:14-18.
64. Corredoira Sanchez JC, Casariego Vales E, Alonso Garcia P, et al. Bacteremia in the elderly. Clinical features and prognostic factors. Med Clin (Barc) 1997; 109: 165-70.
65. Bradley SF. Issues in the management of resistant bacteria in long-term care facilities. Infect Control Hosp Epidemiol 1999; 20: 362-6.
66. Bentley DW, Bradley S, High K, Schoenbaum S, Taler G, Yoshikawa TT. Practice guideline for evaluation of fever and infection in long-term care facilities. J Am Geriatr Soc 2001; 49: 210-22.
67. Nicolle LE. Urinary tract infections in long-term care facilities. Infect Control Hosp Epidemiol 2001; 22: 167-75.
68. McCusker J, Cole M, Abrahamowicz M, Han L, Podoba JE, Ramman-Haddad L. Environmental risk factors for delirium in hospitalized older people. J Am Geriatr Soc 2001; 49: 1327-34.
69. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis 2002; 2: 145-55.
70. Pneumococcal and influenza vaccination levels among adults aged > or= 65 years - United States, 1995. MMWR Morb Mortal Wkly Rep 1997; 46: 913-19.
71. Ortqvist A. Pneumococcal vaccination: Current and future issues. Eur Respir J 2001; 18: 184-95.
72. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: A randomised controlled trial. Lancet 2000; 355: 93-97.
73. Murasko DM, Bernstein ED, Gardner EM, et al. Role ofhumoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002; 37: 427-39.
74. Saurwein-Teissl M, Lung TL, Marx F, et al. Lack of antibody production following immunization in old age: Association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168: 5893-99.
75. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000; 31: 578-85.
76. Ben-Yehuda A, Weksler ME. Host resistance and the immune system. Clin Geriatr Med 1992; 8: 701-11.
77. Goyns MH. Genes, telomeres and mammalian ageing. Mech Ageing Dev 2002; 123: 791-99.
78. Chandra RK. Nutrition, immunity and infection: From basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. Proc Natl Acad Sci USA 1996; 93: 14304-07.
79. Constans T, Bacq Y, Brechot JF, Guilmot IL, Choutet P, Lamisse F. Protein-energy malnutrition in elderly medical patients. J Am Geriatr Soc 1992; 40: 263-68.
80. Lesourd BM, Mazari L, Ferry M. The role of nutrition in immunity in the aged. Nutr Rev 1998; 56: S113-25.
81. Sullivan DH, Sun S, Walls RC. Protein-energy undernutrition among elderly hospitalized patients: A prospective study. JAMA 1999; 281: 2013-19.
82. Yeh SS, Schuster MW. Geriatric cachexia: The role of cytokines. Am J Clin Nutr 1999; 70: 183-97.
83. Lesourd B. Immune response during disease and recovery in the elderly. Proc Nutr Soc 1999; 58: 85-98.
84. Lesourd BM. Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. Am J Clin Nutr 1997; 66: S478-84.
85. Gershwin ME, Borchers AT, Keen CL. Phenotypic and functional considerations in the evaluation of immunity in nutritionally compromised hosts. J Infect Dis 2000; 182: S108-14.
86. High KP. Nutritional strategies to boost immunity and prevent infection in elderly individuals. Clin Infect Dis 2001; 33: 1892-900.
87. Krabbe KS, Bruunsgaard H, Hansen CM, et al. Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 2001; 8: 333-38.
88. Bruunsgaard H, Skinhoj P, Qvist J, Pedersen BK. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis 1999; 180: 551-54.
89. Riquelme R, Torres A, el-Ebiary M, et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med 1997; 156: 1908-14.
90. Kyle UG, Morabia A, Slosman DO, Mensi N, Unger P, Pichard C. Contribution of body composition to nutritional assessment at hospital admission in 995 patients: A controlled population study. Br J Nutr 2001; 86: 725-31.
91. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, part I: History, examination, body composition, and screening tools. Nutrition 2000; 16: 50-63.
92. Vellas B, Lauque S, Andrieu S, et al. Nutrition assessment in the elderly. Curr Opin Clin Nutr Metab Care 2001; 4: 5-8.
93. Potter JM. Oral supplements in the elderly. Curr Opin Clin Nutr Metab Care 2001; 4: 21-28.
94. Yamaya M, Yanai M, Ohrui T, Arai H, Sasaki H. Interventions to prevent pneumonia among older adults. J Am Geriatr Soc 2001; 49: 85-90.
95. Incalzi RA, Maini CL, Fuso L, Giordano A, Carbonin PU, Galli G. Effects of aging on mucociliary clearance. Compr Gerontol [A] 1989; 3: 65-68.
96. Meyer KC. The role of immunity in susceptibility to respiratory infection in the aging lung. Respir Physiol 2001; 128: 23-31.
97. Yoshikawa TT, Nicolle LE, Norman DC. Management of complicated urinary tract infection in older patients. J Am Geriatr Soc 1996; 44: 1235-41.
98. Stamm WE, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999; 28: 723-25.
99. Klontz KC, Adler WH, Potter M. Age-dependent resistance factors in the pathogenesis of foodborne infectious disease. Aging (Milano) 1997; 9: 320-26.
100. Pilotto A, Malfertheiner P. An approach to Helicobacter pylori infection in the elderly. Aliment Pharmacol Ther 2002; 16: 683-91.
101. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-28.
102. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-54.
103. Kannel WB. Overview of atherosclerosis. Clin Ther 1998; 20: B2-17.
104. Horejsi B, Ceska R. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein (a) as candidate genes of premature development of atherosclerosis. Physiol Res 2000; 49: S63-9.
105. Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis - What we know and what we don't. Clin Microbiol Infect 2002; 8: 2-13.
106. Shay K. Infectious complications of dental and periodontal diseases in the elderly population. Clin Infect Dis 2002; 34: 1215-23.
107. Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 2002; 90: 2-4.
108. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997; 350: 430-36.
109. Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: The atherosclerosis risk in communities (ARIC) study. Arch Intern Med 2000; 160: 2027-32.
110. Rupprecht HJ, Blankenberg S, Bickel C, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001; 104: 25-31.
111. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002; 105: 15-21.
112. Lin WR, Wozniak MA, Wilcock GK, Itzhaki RF. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis 2002; 9: 82-87.
113. Dobson CB, Itzhaki RF. Herpes simplex virus type 1 and Alzheimer's disease. Neurobiol Aging 1999; 20: 457-65.
114. Balin BJ, Gerard HC, Arking EJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (Berl) 1998; 187: 23-42.
115. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type I in brain and risk of Alzheimer's disease. Lancet 1997; 349: 241-44.
116. Markewitz BA, Owens MW, Payne DK. The pathogenesis of chronic obstructive pulmonary disease. Am J Med Sci 1999; 318: 74-78.
117. Hogg JC. Latent adenoviral infection in the pathogenesis of emphysema: the Parker B. Francis Lectureship. Chest 2000; 117: 282S-5S.
118. Bestilny LJ, Gill MJ, Mody CH, Riabowol KT. Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS 2000;14:771-80.
119. Marcus EL, Clarfield AM, Moses AE. Ethical issues relating to the use of antimicrobial therapy in older adults. Clin Infect Dis 2001; 33: 1697-705.
120. Olmari-Ebbing M, Zumbach CN, Forest MI, Rapin CH. Advance directives, a tool to humanize care. Rev Med Suisse Romande 2000; 120: 581-84.